share_log

Tiziana Life Sciences Doses First Patient With Intranasal Foralumab With Moderate Alzheimer's Disease

Tiziana Life Sciences Doses First Patient With Intranasal Foralumab With Moderate Alzheimer's Disease

Tiziana Life Sciences 對第一位中度阿爾茨海默病患者進行了鼻用Foralumab的給藥
Benzinga ·  12/17 20:06

Tiziana Life Sciences Doses First Patient With Intranasal Foralumab With Moderate Alzheimer's Disease

Tiziana Life Sciences 給首位患有中度阿爾茨海默氏病的患者服用鼻內福魯單抗

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論